Kanagawa, Japan

Yukihiro Ikeda

USPTO Granted Patents = 3 


Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Yukihiro Ikeda

Introduction

Yukihiro Ikeda is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in improving the solubility of organic compounds. With a total of 3 patents to his name, Ikeda continues to push the boundaries of innovation in his industry.

Latest Patents

One of his latest patents involves a cocrystal designed to enhance the solubility of an organic compound. This cocrystal consists of (1) 6-ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide and (2) L-malic acid or L-tartaric acid. This innovative approach aims to address solubility challenges faced in pharmaceutical formulations.

Career Highlights

Yukihiro Ikeda is currently associated with Takeda Pharmaceutical Company Limited, where he applies his expertise in drug development. His work focuses on creating solutions that enhance the effectiveness of pharmaceutical compounds. His contributions have been instrumental in advancing the company's research initiatives.

Collaborations

Ikeda has collaborated with esteemed colleagues such as Kentaro Iwata and Masatoshi Karashima. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Yukihiro Ikeda's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations highlight his commitment to improving drug solubility and efficacy. Through his efforts, he continues to make a lasting impact on the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…